Amos Bar-Shalev, Director at Protalix BioTherapeutics, Inc. (PLX), bought 1,680 shares at $8.68 ($14K) on 2009-12-02, disclosed to the SEC on 2009-12-09.
Open-market purchase of $14k PLX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.20 | 680 | $6K | 39.1% |
| 2 | $8.68 | 1,000 | $9K | 60.9% |
| Total | $8.49 avg | 1,680 | $14K | 100% |